These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 33925284)
21. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Boden WE; Pearson TA Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282 [TBL] [Abstract][Full Text] [Related]
29. Regulation of reverse cholesterol transport and clinical implications. Rader DJ Am J Cardiol; 2003 Aug; 92(4A):42J-49J. PubMed ID: 12957326 [TBL] [Abstract][Full Text] [Related]
31. Current concept of reverse cholesterol transport and novel strategy for atheroprotection. Ono K J Cardiol; 2012 Nov; 60(5):339-43. PubMed ID: 23063661 [TBL] [Abstract][Full Text] [Related]
32. Should low high-density lipoprotein cholesterol (HDL-C) be treated? Toth PP; Barylski M; Nikolic D; Rizzo M; Montalto G; Banach M Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):353-68. PubMed ID: 24840264 [TBL] [Abstract][Full Text] [Related]
33. HDL-Targeting Therapeutics: Past, Present and Future. Zakiev E; Feng M; Sukhorukov V; Kontush A Curr Pharm Des; 2017; 23(8):1207-1215. PubMed ID: 27799042 [TBL] [Abstract][Full Text] [Related]
34. High-density lipoprotein cholesterol and the role of statins. Chong PH; Kezele R; Franklin C Circ J; 2002 Nov; 66(11):1037-44. PubMed ID: 12419937 [TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein cholesterol increase and non-cardiovascular mortality: a meta-analysis. Burillo E; Andres EM; Mateo-Gallego R; Fiddyment S; Jarauta E; Cenarro A; Civeira F Heart; 2010 Sep; 96(17):1345-51. PubMed ID: 20801853 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Chapman MJ Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234 [TBL] [Abstract][Full Text] [Related]
37. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia. Goa KL; Barradell LB; Plosker GL Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820 [TBL] [Abstract][Full Text] [Related]
38. The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease. Windler E; Schöffauer M; Zyriax BC Diab Vasc Dis Res; 2007 Jun; 4(2):136-42. PubMed ID: 17654448 [TBL] [Abstract][Full Text] [Related]
39. Role of HDL in those with diabetes. Santos-Gallego CG; Rosenson RS Curr Cardiol Rep; 2014 Aug; 16(8):512. PubMed ID: 24950673 [TBL] [Abstract][Full Text] [Related]
40. After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes? Colhoun H Lancet; 2005 Nov; 366(9500):1829-31. PubMed ID: 16310536 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]